Janux Therapeutics Inc (JANX)
45.37
+2.35
(+5.46%)
USD |
NASDAQ |
May 24, 16:00
45.37
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics Total Liabilities (Quarterly): 33.22M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 33.22M |
| December 31, 2023 | 36.06M |
| September 30, 2023 | 37.90M |
| June 30, 2023 | 42.03M |
| March 31, 2023 | 41.69M |
| December 31, 2022 | 43.27M |
| September 30, 2022 | 44.24M |
| Date | Value |
|---|---|
| June 30, 2022 | 41.55M |
| March 31, 2022 | 12.52M |
| December 31, 2021 | 13.50M |
| September 30, 2021 | 14.33M |
| June 30, 2021 | 12.03M |
| March 31, 2021 | 88.59M |
| December 31, 2020 | 30.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.03M
Minimum
Jun 2021
88.59M
Maximum
Mar 2021
35.13M
Average
36.98M
Median
Total Liabilities (Quarterly) Benchmarks
| Viking Therapeutics Inc | 33.63M |
| Equillium Inc | 22.50M |
| Minerva Neurosciences Inc | 87.10M |
| Arvinas Inc | 602.90M |
| Calidi Biotherapeutics Inc | 21.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 688.98M |
| Shareholders Equity (Quarterly) | 655.76M |
| Current Ratio | 62.09 |